Key result
Dobutamine stress echocardiography is a safe, feasible, and valuable technique for evaluating coronary artery disease in patients unable to exercise.
Why the study?
Is dobutamine stress echocardiography a safe and valuable technique for the noninvasive evaluation of coronary artery disease in patients unable to exercise?
Is dobutamine stress echocardiography a safe and valuable technique for the noninvasive evaluation of coronary artery disease in patients unable to exercise?
Dobutamine stress echocardiography is a safe and feasible alternative for evaluating coronary artery disease in patients unable to undergo exercise testing.
May support dobutamine stress echo in exercise-intolerant patients; leaves open need for randomized validation before changing practice.
Exercise electrocardiography is an established mode of evaluation for patients with suspected coronary artery disease. It also provides prognostic information and guides therapeutic management in patients with established disease. However, some patients are unable to exercise because of orthopedic problems, neurologic diseases, peripheral vascular disease, or deconditioning. In the past, these patients have been referred for angiography to help assess their disease. Recently, however, new techniques to assess myocardial perfusion and/or function, including stress echocardiography, have been used in the noninvasive assessment of coronary artery disease in this group of patients. Echocardiography has been used in combination with different drugs, including dobutamine, dipyridamole, and adenosine. Dobutamine is probably the single most studied drug for stress echocardiography. Dobutamine stress echocardiography is a safe, feasible, and valuable technique for evaluating coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Ernest C. Madu (1994) conducted a review in Coronary artery disease. Dobutamine stress echocardiography was evaluated. Dobutamine stress echocardiography is a safe, feasible, and valuable technique for evaluating coronary artery disease in patients unable to exercise.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: